Buenos Aires, Argentina

Silvia Leis De Cerone

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Silvia Leis De Cerone. Retrieved from https://idiyas.com/inventor/silvia-leis-de-cerone

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 39(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Silvia Leis De Cerone: Innovator in Monoclonal Antibodies

Introduction

Silvia Leis De Cerone is a prominent inventor based in Buenos Aires, Argentina. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work focuses on innovative solutions for cancer diagnosis and treatment.

Latest Patents

Silvia holds a patent for "Monoclonal antibodies reactive with tumor proliferating cells." This invention is particularly relevant to breast carcinoma, as it involves the production of immunoglobulin-secreting hybridoma cultures. These cultures are created using undifferentiated breast cancer cells as antigens for immunization. The selected hybridomas produce antibodies that are highly reactive with tumor proliferating cells. This advancement has important applications in aiding the diagnosis and treatment of cancer.

Career Highlights

Throughout her career, Silvia has demonstrated a commitment to advancing medical science. Her innovative approach to developing monoclonal antibodies has positioned her as a key figure in cancer research. With a patent portfolio that includes her groundbreaking work, she continues to influence the field significantly.

Collaborations

Silvia has collaborated with notable professionals in her field, including Jose Mordoh and Osvaldo Luis Podhajcer. These partnerships have enhanced her research and contributed to the success of her inventions.

Conclusion

Silvia Leis De Cerone is a trailblazer in the field of biotechnology, particularly in the development of monoclonal antibodies for cancer treatment. Her innovative work and collaborations have made a lasting impact on medical research and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…